NEW YORK (AP) -- Irish drug and medical device maker Covidien PLC said Tuesday that it completed its acquisition of Oridion Systems Ltd.
Oridion, based in Israel, makes devices that monitor breathing and give early indications that a patient's airway could be compromised. It had $64 million in revenue in 2011.
Covidien said the acquisition expands its product lineup with a key monitoring technology that will complement its existing pulse oximeter and monitoring product lines.
Covidien said it completed the deal for about $310 million, net of cash and acquired investments.
Covidien shares finished at $52.25 on Monday. They have traded in a 52-week range of $41.35 to $56.20.
